GlassScriptPhysician profile
Priyanka Batchu
NPI 1649638586
$3,144.30
in general payments reported to CMS, 2019-2025
31 companies · $205 in 2025
The $205 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $470 · 2020: $145 · 2021: $848 · 2022: $293 · 2023: $656 · 2024: $528 · 2025: $205.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,389.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,388.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $594.87 | 2019-2025 | Lifevest |
| Abbott Laboratories | $486.07 | 2019-2023 | Thoratec Heartmate 3 Lvas Implant Kit |
| Novartis Pharmaceuticals Corporation | $238.10 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $206.62 | 2019-2023 | Brilinta, Farxiga |
| Amgen INC. | $191.52 | 2021-2025 | Repatha, Repatha |
| Impulse Dynamics (USA) INC. | $173.29 | 2021-2025 | Optimizer, Optimizer |
| Pfizer INC. | $155.78 | 2019-2025 | |
| Cvrx, INC. | $148.69 | 2021 | |
| Cardiovascular Systems INC. | $127.81 | 2019-2021 | |
| Boston Scientific Corporation | $118.04 | 2020-2025 | Watchman Flx, Bodyguardian |
| Philips North America LLC | $97.56 | 2023-2024 | (5044) Mcot, (5050) Extended Holter |
| Chiesi USA, INC. | $95.41 | 2022 | |
| Novo Nordisk INC | $58.25 | 2023 | Ozempic, Rybelsus |
| E.R. Squibb & Sons, L.L.C. | $56.08 | 2021-2024 | Eliquis |
| Portola Pharmaceuticals, LLC | $44.07 | 2019-2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $40.27 | 2021-2022 | |
| Kiniksa Pharmaceuticals International, Plc | $34.02 | 2024 | Arcalyst |
| Janssen Pharmaceuticals, INC | $32.00 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $30.78 | 2023 | Aralast |
| Teleflex LLC | $26.69 | 2019 | |
| Livanova USA, INC. | $26.21 | 2019 | |
| Scpharmaceuticals INC. | $19.95 | 2024 | |
| Akcea Therapeutics, INC. | $19.79 | 2020 | |
| Sanofi-Aventis U.S. LLC | $19.22 | 2024 | |
| Terumo Medical Corporation | $16.33 | 2024 | Metacross Otw, Progreat, Glidewire |
| Kestra Medical Technology Services, INC. | $15.30 | 2023 | Assure Wcd |
| W. L. Gore & Associates, INC. | $15.28 | 2024 | Gore Cardioform Septal Occluder |
| Kiniksa Pharmaceuticals, LTD. | $15.00 | 2023 | Arcalyst |
| Alexion Pharmaceuticals, INC. | $14.22 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $13.80 | 2025 | |
| Actelion Pharmaceuticals US, INC. | $13.28 | 2023 | Opsumit, Uptravi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Priyanka Batchu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.